Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide

Journal of Experimental Medicine

Volumn 206, Issue 8, 2009, Pages 1709-1716

  Coulombe, François ^a   Divangahi, Maziar ^a   Veyrier, Frédéric ^a   De Léséleuc, Louis ^a   Gleason, James L ^b   Yang, Yibin ^c   Kelliher, Michelle A ^c   Pandey, Amit K ^c   Sassetti, Christopher M ^c   Reed, Michael B ^a   Behr, Marcel A ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MURAMYL DIPEPTIDE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ACTINOMYCETALES INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC COMPLEMENTATION; INNATE IMMUNITY; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM SMEGMATIS; NOCARDIA; NONHUMAN; PRIORITY JOURNAL; RHODOCOCCUS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ACTINOBACTERIA; ANIMALS; BASE SEQUENCE; CYTOKINES; DNA, BACTERIAL; FEMALE; GLYCOLS; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIXED FUNCTION OXYGENASES; MODELS, IMMUNOLOGICAL; MUTATION; MYCOBACTERIUM SMEGMATIS; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 68149126054     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081779     Document Type: Article

References (25)

1. Adam, A., J.F. Petit, J. Wietzerbin-Falszpan, P. Sinay, D.W. Thomas, and E. Lederer. 1969. FEBS Lett. 4:87-92.
2. Divangahi, M., S. Mostowy, F. Coulombe, R. Kozak, L. Guillot, F. Veyrier, K.S. Kobayashi, R.A. Flavell, P. Gros, and M.A. Behr. 2008. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 181:7157-7165.
3. Ellouz, F., A. Adam, R. Ciorbaru, and E. Lederer. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59:1317-1325.
4. Ferwerda, G., S.E. Girardin, B.J. Kullberg, L. Le Bourhis, D.J. De Jong, D.M. Langenberg, R. Van Crevel, G.J. Adema, T.H. Ottenhoff, J.W. Van Der Meer, and M.G. Netea. 2005. NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog. 1:e34.
5. Ferwerda, G., B.J. Kullberg, D.J. De Jong, S.E. Girardin, D.M. Langenberg, R. Van Crevel, T.H. Ottenhoff, J.W. Van Der Meer, and M.G. Netea. 2007. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J. Leukoc. Biol. 82:1011-1018.
6. Freund, J. 1951. The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review. Am. J. Clin. Pathol. 21:645-656.
7. Freund, J. 1956. The mode of action of immunologic adjuvants. Bibl. Tuberc. 1956:130-148.
8. Freund, J., M.M. Lipton, and L.R. Morrison. 1950. Demyelination in the guinea pig in chronic allergic encephalomyelitis produced by injecting guinea pig brain in oil emulsion containing a variant of Mycobacterium butyricum. Arch. Pathol. (Chic). 50:108-121.
9. Gandotra, S., S. Jang, P.J. Murray, P. Salgame, and S. Ehrt. 2007. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 75:5127-5134.
10. Girardin, S.E., I.G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D.J. Philpott, and P.J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869-8872.
11. Hasegawa, M., Y. Fujimoto, P.C. Lucas, H. Nakano, K. Fukase, G. Nunez, and N. Inohara. 2008. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 27:373-383.
12. Hugot, J.P., M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, J. Belaiche, S. Almer, C. Tysk, C.A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:599-603.
13. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:5509-5512.
14. Kobayashi, S., T. Fukuda, H. Yukimasa, M. Fujino, I. Azuma, and Y. Yamamura. 1980. Synthesis of muramyl dipeptide analogs with enhanced adjuvant activity. Bull. Chem. Soc. Jpn. 53:2570-2577.
15. Kotani, S., Y. Watanabe, F. Kinoshita, T. Shimono, and I. Morisaki. 1975. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J. 18:105-111.
16. Kufer, T.A., and P.J. Sansonetti. 2007. Sensing of bacteria: NOD a lonely job. Curr. Opin. Microbiol. 10:62-69.
17. Leber, J.H., G.T. Crimmins, S. Raghavan, N.P. Meyer-Morse, J.S. Cox, and D.A. Portnoy. 2008. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4:e6.
18. Lederer, E., A. Adam, R. Ciorbaru, J.F. Petit, and J. Wietzerbin. 1975. Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol. Cell. Biochem. 7:87-104.
19. Mahapatra, S., H. Scherman, P.J. Brennan, and D.C. Crick. 2005. N glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J. Bacteriol. 187:2341-2347.
20. Masihi, K.N., W. Brehmer, W. Lange, H. Werner, and E. Ribi. 1985. Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide. Infect. Immun. 50:938-940.
21. Raymond, J.B., S. Mahapatra, D.C. Crick, and M.S. Pavelka Jr. 2005. Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. J. Biol. Chem. 280:326-333.
22. Stewart-Tull, D.E. 1980. The immunological activities of bacterial peptidoglycans. Annu. Rev. Microbiol. 34:311-340.
23. Wolfert, M.A., T.F. Murray, G.J. Boons, and J.N. Moore. 2002. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277:39179-39186.
24. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69:2045-2053.
25. Yang, Y., C. Yin, A. Pandey, D. Abbott, C. Sassetti, and M.A. Kelliher. 2007. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282:36223-36229.